Warrant
Issued 2023
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 27 of Yarrow Bioscience, Inc.'s SEC filings and found 4 warrant series, 1 convertible, 1 ATM program, 2 shelf registrations and 2 completed offerings on file for YARW. Analysis updated Oct 6, 2026.
Raise routes on file: active ATM + effective shelf · latest dilution event 54 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Sep 10, 2026 · Offering Priced
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2023
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Principal
Conversion Price
Issued 2024
Total capacity
Sold to date
Issued 2024
Total capacity
Remaining
Issued 2023
Total capacity
Remaining
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z